Endothelial function, systemic inflammation and cardiac hemodynamics in different age patients with post infarction chronic heart failure.

Authors

  • Abdunaser A.M. Zabida

DOI:

https://doi.org/10.26641/2307-0404.2018.1.124918

Keywords:

myocardial infarction, endothelial dysfunction, cardiac hemodynamics

Abstract

Heart failure (HF) is a major cause of morbidity and mortality. After myocardial infarction, physiological and anatomical ventricular changes occur, There is also an inflammatory reaction with release of cytokines, growth factors and reactive oxygen species production, which contributes to perpetuate ventricular dysfunction. The study was designed to evaluate the level of inflammatory markers (white blood cells and C-reactive protein), endothelial function and cardiac hemodynamic in different age patients with post infarction heart failure. We divided 45 patients with HF with preserved ejection fraction (HFpEF) with mean age 67,5 [65,5; 71,7] years into two main groups. 1st group: 25 patients with HFpEF and history of myocardial infarction. 2nd group: 20 patients with HFpEF and stable angina (without myocardial infarction in anamnesis). Standard laboratory blood tests for erythrocyte sedimentation rate, C-reactive protein, haematological parameters, lipid profile, glucose, renal and liver function tests, echocardiographic examination, endothelial function estimation were performed. Patients with a history of myocardial infarction had significantly higher levels of left ventricle end diastolic volume, left ventricle end systolic dimension (p<0.05). There was estimated direct correlation between LVEDV, LVESD and age - R=0.68 (p<0.05), R=0.52 (p<0.05). Further analysis of cardiac hemodynamics depending on age revealed significant differences between LVEDV indices in patients with myocardial infarction. A significantly higher level of leukocytes was found in patients with HFpEF with a history of myocardial infarction in both groups (p<0.05). A direct correlation between the leukocyte count and age in patients with HFpEF-R = 0.48 (p< 0.05) was also found. Patients with HFpEF with a history of myocardial infarction had a significantly higher level of CRP, including in the age aspect (p<0.05). A direct correlation between CRP level and age was established in patients with HFpEF - R=0.46 (p<0.05). It was revealed that in the older age groups with myocardial infarction the signs of endothelial dysfunction were significantly more frequent (p<0.05). Reverse correlations were established between the level of endothelium dependent vasodilatation (ESVD) and CRP (R=-0.48, p<0.05), triglycerides (R=-0.45, p<0.05), diastolic blood pressure (R=-0.54, p<0.05). Conclusion: high level of inflammation markers, endothelial dysfunction and changes in cardiac hemodynamics were recorded more often in elderly patients with post infarction heart failure.

Author Biography

Abdunaser A.M. Zabida

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of Internal Medicine 2
(Head of department – prof. O.V. Kuryata)
V. Vernadsky str., 9, Dnipro, 49044, Ukraine

References

Kuryata OV, Sirenko OYu. [Effect of L-arginine aspartate on endothelial function of blood vessels in patients with arterial hypertension combined with rheu­matoid arthritis]. Ukrayinsʹkyy medychnyy chasopys. 2014;5(103):64-66. Ukrainian.

Kuryata OV, Sіrenko OYu. [Subclinical mani­festations of atherosclerosis, functional state of the edema and rigidity of vessels in patients with arterial hyper­tension combined with rheumatoid arthritis]. Aktualʹni prob­lemy suchasnoyi medytsyny: Visnyk Ukrayinsʹkoyi me­dychnoyi stomatolohichnoyi akademiyi. 2014;3(47):89-95. Ukrainian.

Kuryata AV, Lysunets TK, Noda OYu. [Cochra­nitis effectiveness in complex therapy in patients with systemic connective tissue diseases with myocardial damage and manifestations of heart failure]. Mezhdu­narodnyy meditsinskiy zhurnal. 2012;2:44-49. Russian.

Rubinshtein R, Kuvin JT, Soffler M, et al. As­sessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J. 2010;31:1142-8.

Thijssen DHJ, Black MA, Pyke K, Padilla J, At­kinson GA, Harris RA, Parker B, Widlansky ME, Tscha­ko­vsky ME, Green DJ. Assessment of flow media­ted dila­tion (fmd) in humans: a methodological and physiological gui­deline. Am J Physiol Heart Circ Physiol. 2011;300:H2–H12.

Bauersachs J, Widder JD. Endothelial dysfunction in heart failure. Pharmacol Rep 2008;60:119-26.

Yeboah J, Crouse JR, Hsu FC, Burke GL, Her­rington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardio­vascular Health Study. Circulation. 2007;115: 390-7.

Philpott AC, Lonn E, Title LM, Verma S, Buit­hieu J, Charbonneau F, Anderson TJ. Comparison of new measures of vascular function to flow mediated dilatation as a measure of cardiovascular risk factors. Am J Cardiol. 2009;103:1610-15.

Vanhoutte PM, Shimokawa H, Tang EH, Feletou M. Endothelial dysfunction and vascular disease. Acta Physiol (Oxf). 2009;196:193-222.

de Berrazueta JR, Guerra-Ruiz A,Garcia-UnzuetaMT, et al. Endothelial dysfunction, measured by reactive hyperaemia using strain-gauge plethysmography, is an independent predictor of adverse outcome in heart failure. Eur J Heart Fail 2010;12:477-83.

Ponikowski P, et al. 2016 ESC Guidelines for the diagnosis and treatment The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC) Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016;37 (27):2129-200.

Nikolaos G Frangogiannis. The inflammatory response in myocardial injury, repair, and remodelling. Nature Reviews Cardiology. 2014;11:255-65.

Gajarsa JJ, Kloner RA: Left ventricular remod­eling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Fail Rev. 2011;16(1):13-21.

Raposeiras Roubín S, Pardal C Barreiro, Roubín-Camiña F, R Ocaranza Sanchez, E Alvarez Castro, B Pa­radela Dobarro, et al. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment eleva­tion acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial in­farction. Rev Port Cardiol. 2013;32:117-22.

Hwang SJ, Melenovsky V, Borlaug BA. Implica­tions of coronary artery disease in heart failure with pre­served ejection fraction. J. AmColl Cardiol. 2014;63(25, ptA):2817-27.

Black MA, Cable NT, Thijssen DH, Green DJ. Importance of measuring the time course of flowmediated dilatation in humans. Hypertension 2008;51:203-10.

Inaba Y, Chen JA, Bergmann SR. Prediction of future cardiovascular outcomes by flow-mediated vaso­dilatation of the brachial artery: a meta-analysis. Int J Car­diovasc Imag. 2010;26:631-40.

Akiyama E, Sugiyama S, Matsuzawa Y, et al. Incremental prognostic significance of peripheral endo­thelial dysfunction in patients with heart failure with nor­mal left ventricular ejection fraction,” Journal of the American College of Cardiology. 2012;60(18):1778-86.

Donald AE, Halcox JP, Charakida M, et al. Me­thodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation. J Am Coll Cardiol. 2008;51:1959-64.

Chen J, Hsieh AF, Dharmarajan K, Masoudi FA, Krumholz HM. National trends in heart failure hospi­ta­li­zation after acutemyocardial infarction for Medicare be­ne­ficiaries: 1998-2010. Circulation. 2013;128(24):2577-84.

Arroyo Espliguero R, Avanzas P, Quiles J, Kaski JC. Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease Atherosclerosis. 2009;204:239-43.

De Keulenaer GW, Segers VFM, Zannad F, and Brutsaert DL. The future of pleiotropic therapy in heart failure. Lessons from the benefits of exercise training on endothelial function. European Journal of Heart Failure. 2017;19:603-14.

Torabi A, Cleland JG, Khan NK, et al. The timing of development and subsequent clinical course of heart failure after a myocardial infarction. Eur Heart J. 2008;29:859-870.

Shechter M, Matetzky S, Arad M, Feinberg MS, Freimark D. Vascular endothelial function predicts morta­lity risk in patients with advanced ischaemic chronic heart failure. Eur J Heart Fail. 2009;11:588-93.

Zornoff LA, Paiva SA,Duarte DR, Spadaro J. Ven­tricular remodeling after myocardial infarction: con­cepts and clinical implications. Arq Bras Cardiol. 2009;92(2):157-64.

Downloads

How to Cite

1.
Zabida AA. Endothelial function, systemic inflammation and cardiac hemodynamics in different age patients with post infarction chronic heart failure. Med. perspekt. [Internet]. 2018Apr.2 [cited 2024Dec.23];23(1):15-22. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/124918

Issue

Section

CLINICAL MEDICINE